TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Normalization of the Reflux Symptom Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Cmax (Maximum plasma concentration of the drug at steady state)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUCtau (Area under the plasma concentration-time curve for a dosing interval at steady state)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resting State Brain Network Organization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Task-Based Brain Network Organization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Rest-Task Reconfiguration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Drug-induced Normalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Stability of anterior chamber and pupil
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time of operation
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cumulative dissipated energy (CDE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Optimal Timing For AEEG Recording
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in EASI (eczema severity score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Outcome of TIPS for PVT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: mid-luteal serum progesterone level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: spot cortisol level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Child's Health Related Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Speed of Communication
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Post-operative Clinical Findings of Cystoid Macular Edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Presence or absence of live lice
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Resolution of treated lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Non-transferrin-bound Iron Level (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Combined effective rate of blood pressure and plasma homocysteine reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Feasibility of Assessment Procedures: completion rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean left ventricular end-systolic volume index (LVESVI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Amount of new permanent injury detected in late CMRI study
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Anti factor Xa activity dosage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain at Time of IUD Insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants with blood pressure elevation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Knee separation during the Drop Jump Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Ossification Quality Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of women with genitourinary events Grade 1 or higher
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of women with adverse events Grade 2 or higher
Endpoint domain: Adverse events/effects
Primary endpoint: Evidence of Arthrodesis (Fusion)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Ki67 Tumor Proliferation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Efficacy of olanzapine doses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of analgesia assessed by VAS for pain at rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of analgesia assessed by VAS for pain on movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of haemorrhagic complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of clinically relevant adverse changes in clinical laboratory tests
Endpoint domain: Adverse events/effects
Primary endpoint: Number of clinically relevant adverse changes in vital signs
Endpoint domain: Adverse events/effects
Primary endpoint: Number of clinically relevant adverse changes in 12-lead ECGs
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients with clinically relevant findings in vital signs (blood pressure, pulse rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of patients with abnormal findings in 12-lead electrocardiogram (ECG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from baseline in potassium level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Prevalence of lung cancers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Liver appearance on ultrasound
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Count of participants with sustained mixed chimerism of >25% at 18 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Count of participants able to withdraw from immunosuppressive drugs without evidence of rejection at 18 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Numeric Pain Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Number of patients who died in intensive care
Endpoint domain: Mortality/survival
Primary endpoint: Number of patients who were intubated in intensive care
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Body image outcomes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Total number of participating sites
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: TM angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in visual disability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30-day crude mortality
Endpoint domain: Mortality/survival
Primary endpoint: Observed Ctrough at Week 22
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Money Spent Between Baseline and Relapse Phase
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Level of carotenoids in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Quality-adjusted life years for each screening strategy
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Psychometric validity of the STO22 module
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pain (rest, moment)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Active and passive ROM of knee (flexion and extension)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Local Knee function e.g. KSKS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inhibition of UFC growth of S Mutans count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Micro tensile bond strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MMPs' activity (Units of fluorescence)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Infusion site reaction
Endpoint domain: Adverse events/effects
Primary endpoint: Change in urinary output
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Toleration of combination of fulvestrant/vandetanib
Endpoint domain: Adverse events/effects
Primary endpoint: Chest strap data quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of patients with grade 3 pneumonitis
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of Thyroid cancer evolving to refractory stage
Endpoint domain: Mortality/survival
Primary endpoint: Ocular Refraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Airway responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Meters Walked During 2-Minute Walk Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of insulin-independence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: complete polyp resection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Recurrence rates of CRA
Endpoint domain: Mortality/survival
Primary endpoint: EAT thermoregulatory genes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prechtl's General Movements Assessment (GMA) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: The Test of Infant Motor Performance (TIMP) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Alberta Infant Motor Scale (AIMS) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Hammersmith Infant Neurological Examination (HINE) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: incidence of LARS
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of major LARS
Endpoint domain: Adverse events/effects
Primary endpoint: Response rate to VID combination therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Subjects with Complete or Partial Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of blood tryptase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in CogState aggregated test score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in CSF Homocysteine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cytotoxic T-cell Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change from Baseline in Crohn's Disease Activity Index (CDAI) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in C-reactive Protein (CRP) Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in Harvey-Bradshaw Index (HBI) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in Fecal Calprotectin Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cocaine & benzoylecgonine content
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maternal gestational weight gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Adverse drug event-related hospital revisits
Endpoint domain: Adverse events/effects
Primary endpoint: Wheal Formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Composite of death, myocardial infarction or stroke
Endpoint domain: Mortality/survival
Primary endpoint: Cup migration after 2 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Events of ALT Elevation After Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Change in Matrix Metallo Proteinase 9
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-care ability
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Mucosal Outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Circadian Outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microbiota Outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Patients with Toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Sensitivity of clinical eye movement devices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of clinical eye movement devices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: acute success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: long-term success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of birch pollen allergen inducing conjunctival response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tumour aggressiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Expired-air CO Verified Point-prevalence Abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pelvic Floor Muscle Function Measured by Digital Palpation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Pelvic Floor Muscle Function Measured by Manometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Number of Participants Who Experienced Myocardial Infarction (MI)
Endpoint domain: Mortality/survival
Primary endpoint: Number of Participants Who Experienced Stent Thrombosis (ST)
Endpoint domain: Adverse events/effects
Primary endpoint: Response Rate of Melanoma Lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence of pleural effusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Respiratory symptoms as dyspnea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Ventricular size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Local Tolerability Events of Interest
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With AE and sAE of Different Level of Severity
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants completing treatment periods
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Accuracy of Co-Registration of IVUS and Coronary Angiography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Blood Flow (AU)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Days Until Alleviation of Flu Symptoms Post Treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Days Until Complete Resolution of All Flu Symptoms for 24 Hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Further pleural intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Improvement in intestinal permeability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: change of Visual Analogue Scale (VAS) score
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Change in Myocardial Blood Flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Child Responsiveness to the intervention
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Caregiver Responsiveness to the intervention
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Tissue concentration of ambisome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bile levels of amphotericin B over time (3 weeks)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood levels of amphotericin B over time (3 weeks)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with residual or recurrent adenoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Percentage of Participants Who Achieved Seroprotection at ≥ 0.1 IU/mL Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of Participants Who Achieved Serothreshold at Level ≥ 1.0 IU/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of Participants Who Demonstrated Booster Response for Pertussis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Neonatal sensor glucose time in target
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Safety of modified bCPAP device
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients who achieve target range
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety Overview Within 30 Days
Endpoint domain: Adverse events/effects
Primary endpoint: Pharmacokinetics of total serum iron
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of missed, mistimed, or reduced doses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recruitment with the ePRO application
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: usability of the ePRO application
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: acceptability of the ePRO application
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Days to achieve full feeds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achievement of post-traumatic stress disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scar pain relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in post-operative pain score with intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Opioid related side effects
Endpoint domain: Adverse events/effects
Primary endpoint: 6 Month Self-reported Abstinence From Smoking
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean Cross-sectional Area of Neo-intimal Tissue Coverage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in HbA1C
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum vitamin D3 metabolites levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Peritoneal dialysate effluent CA-125
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PET indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PET signal intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With Asymptomatic Thrombosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percent Change in Total Cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percent Change in LDL-Cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percent Change in HDL Cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percent Change in Triglycerides
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percent Change in TNF-alpha
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percent Change in IL-6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Infant height and weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration Versus Time Curve From Zero up to Infinity (AUC0-inf) of Edaravone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Plasma Concentration (Cmax) of Edaravone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in anterior cingulate cortex glutamate concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Production of cancer antigen-specific T-cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Distance from catheter tip to cavo-atrial junction (CAJ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clearance of urea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: clearance of creatinine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Prevalence of Amyloid A level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes